Jefferies Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.46M | Sell |
31,002
-424,343
| -93% | -$35.8M | 0.02% | 535 |
|
|
2022
Q2 | $33.8M | Sell |
455,345
-273,672
| -38% | -$20.5M | 0.28% | 59 |
|
|
2022
Q1 | $65.5M | Buy |
729,017
+665,200
| +1,042% | +$61.4M | 0.41% | 31 |
|
|
2021
Q4 | $7.14M | Sell |
63,817
-266,433
| -81% | -$32.1M | 0.04% | 358 |
|
|
2021
Q3 | $41.5M | Hold |
330,250
| – | – | 0.3% | 48 |
|
|
2021
Q2 | $44.7M | Sell |
330,250
-144,250
| -30% | -$19M | 0.28% | 53 |
|
|
2021
Q1 | $64.4M | Buy |
474,500
+414,500
| +691% | +$62.1M | 0.56% | 24 |
|
|
2020
Q4 | $8.45M | Sell |
60,000
-58,005
| -49% | -$7.43M | 0.07% | 258 |
|
|
2020
Q3 | $13.1M | Sell |
118,005
-73,798
| -38% | -$8.27M | 0.15% | 100 |
|
|
2020
Q2 | $21.5M | Buy |
191,803
+77,706
| +68% | +$7.65M | 0.25% | 47 |
|
|
2020
Q1 | $8.84M | Buy |
114,097
+65,443
| +135% | +$5.79M | 0.1% | 176 |
|
|
2019
Q4 | $4.63M | Sell |
48,654
-142,335
| -75% | -$12.3M | 0.04% | 554 |
|
|
2019
Q3 | $14.6M | Buy |
190,989
+86,809
| +83% | +$7.21M | 0.11% | 124 |
|
|
2019
Q2 | $9.14M | Buy |
104,180
+52,000
| +100% | +$4.44M | 0.07% | 252 |
|
|
2019
Q1 | $4.72M | Sell |
52,180
-27,575
| -35% | -$2.35M | 0.04% | 463 |
|
|
2018
Q4 | $5.72M | Sell |
79,755
-22,425
| -22% | -$1.81M | 0.05% | 366 |
|
|
2018
Q3 | $9.8M | Buy |
102,180
+100,000
| +4,587% | +$9.7M | 0.06% | 280 |
|
|
2018
Q2 | $208K | Sell |
2,180
-900
| -29% | -$82.7K | ﹤0.01% | 2022 |
|
|
2018
Q1 | $270K | Buy |
3,080
+900
| +41% | +$82.2K | ﹤0.01% | 1846 |
|
|
2017
Q4 | $185K | Sell |
2,180
-800
| -27% | -$67K | ﹤0.01% | 2242 |
|
|
2017
Q3 | $258K | Sell |
2,980
-31,500
| -91% | -$2.53M | ﹤0.01% | 1954 |
|
|
2017
Q2 | $2.66M | Buy |
34,480
+32,300
| +1,482% | +$2.29M | 0.02% | 820 |
|
|
2017
Q1 | $151K | Sell |
2,180
-75,698
| -97% | -$5.08M | ﹤0.01% | 2087 |
|
|
2016
Q4 | $4.61M | Buy |
77,878
+76,728
| +6,672% | +$4.74M | 0.03% | 595 |
|
|
2016
Q3 | $76K | Sell |
1,150
-81,715
| -99% | -$5.06M | ﹤0.01% | 2060 |
|
|
2016
Q2 | $4.48M | Sell |
82,865
-12,390
| -13% | -$679K | 0.02% | 529 |
|
|
2016
Q1 | $4.92M | Buy |
95,255
+94,505
| +12,601% | +$4.91M | 0.03% | 489 |
|
|
2015
Q4 | $53K | Sell |
750
-46,540
| -98% | -$3.17M | ﹤0.01% | 2120 |
|
|
2015
Q3 | $2.94M | Buy |
47,290
+46,540
| +6,205% | +$3.67M | 0.02% | 717 |
|
|
2015
Q2 | $63K | Buy |
+750
| New | +$58.3K | ﹤0.01% | 2360 |
|
|
2014
Q4 | – | Sell |
-750
| Closed | -$42.8K | – | 2384 |
|
|
2014
Q3 | $39K | Buy |
+750
| New | +$38.2K | ﹤0.01% | 2003 |
|
Other funds holding XBI
Jefferies Group's XBI Position: Q3 2022 in Review
Jefferies Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 93% in Q3 2022, selling an estimated $35.8M and leaving 31,002 shares worth $2.46M. The position accounts for 0.02% of the portfolio, ranked #535.
Jefferies Group first reported a position in XBI in Q3 2014 and has held it in 31 quarters since. The position peaked at $65.5M in Q1 2022. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.
- Jefferies Group held 31,002 shares of State Street SPDR S&P Biotech ETF worth $2.46M as of Q3 2022.
- Jefferies Group sold 424,343 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $35.8M.
- State Street SPDR S&P Biotech ETF made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #535 holding.
- Jefferies Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2014 and has held it in 31 quarters since.
- Jefferies Group's State Street SPDR S&P Biotech ETF position peaked at $65.5M in Q1 2022.
- 703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.